Group 1 - The core viewpoint of the news is that Yingke Medical has seen a stock price increase of 5.08%, reaching 41.35 CNY per share, with a trading volume of 174 million CNY and a turnover rate of 0.93%, resulting in a total market capitalization of 27.091 billion CNY [1] - Yingke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017. The company operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Group 2 - From the perspective of major fund holdings, one fund under Huaan Fund has heavily invested in Yingke Medical. The Huaan CSI Medical Device Index Fund A (021469) increased its holdings by 1,200 shares, totaling 18,800 shares, which represents 2.29% of the fund's net value, ranking it as the ninth largest holding [2] - The Huaan CSI Medical Device Index Fund A (021469) was established on November 5, 2024, with a latest scale of 16.7837 million CNY. Year-to-date, it has achieved a return of 3.03%, ranking 3,269 out of 5,580 in its category, and a one-year return of 3.43%, ranking 4,069 out of 4,297. Since its inception, it has incurred a loss of 5.68% [2] Group 3 - The fund manager of Huaan CSI Medical Device Index Fund A (021469) is Su Qingyun, who has a cumulative tenure of 9 years and 70 days. The total asset size of the fund is 10.051 billion CNY, with the best return during the tenure being 131% and the worst return being -62.44% [3]
英科医疗股价涨5.08%,华安基金旗下1只基金重仓,持有1.88万股浮盈赚取3.76万元